Press release
Next Generation Sequencing (NGS) Market Analysis & Upcoming Trends 2017
You can download a sample research report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=574
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of sequences in single run with the use of next generation sequencers. Such technologies have been rapidly developing owing to continuous demand for high-throughput (next generation) sequencers which tend to lower the cost of DNA sequencing.
Geographically, the global market for next generation sequencers is segmented into four major regions, namely, North America, Europe, Asia-Pacific and rest of the world. The funding from federal government and agencies in the U.S. and Canada makes the North American region, the largest market for next generation sequencers. The European and Asian market are also expected to grow substantially due to encouragement by government to use NGS technology.
The major driving factorsfor the global next generation sequencers market are the low cost and speed for DNA sequencing. Other market drivers include the rapid adoption of technology by researchers and academicians, utility for varied application in sequencing and its usability as a substitute for microarray technology.Reduction in the research expenditures by government and university are temporarily impeding the market growth, however the scenario is expected to change once the global economy revives. There is a huge opportunity for NGS technology in the field of biological drug discovery, personalized medicine, agricultural & animal research.
Some of the market players in this industry segment are Agilent Technologies, Inc.,Illumina, Inc., BGI (Beijing Genomics Institute), Biomatters, Ltd., Pacific Biosciences, Dnastar, Inc., Oxford Nanorpore Technologies, Ltd., EMC Corporation, Life Technologies Corporation, Genomatix Software GMBH, Partek Incorporated, Macrogen, Inc., OcimumBiosolutions, Ltd., Perkinelmer, Inc., Qiagen N.V., GATC biotech AG and Knome, Inc.
Browse Full Research Report on Global Next Generation Sequencing (NGS) Market:
http://www.transparencymarketresearch.com/next-generation-sequencers-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Sequencing (NGS) Market Analysis & Upcoming Trends 2017 here
News-ID: 395927 • Views: 359
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for NGS
NGS Data Analysis Market to Undertake Strapping Growth During 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster. This Fact.MR report analyzes the expansion of…
NGS Data Analysis Market to Observe Strong Development by 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster.
Report overview @ https://www.xploremr.com/report/679/ngs-data-analysis-market
This Fact.MR report analyzes…
Next-generation Sequencing (NGS) Market Unbeaten over 2025
Next-generation Sequencing (NGS) Market: Snapshot
Next Generation Sequencing (NGS) is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others. NGS has streamlined nucleotide investigation and has broadly supplanted customary instruments of genomics, particularly microarray effectively. The interest for NGS has expanded altogether inferable from surge in NGS applications and ascend in mechanical progressions in NGS. What's more, the development in…
Next Generation Sequencing (NGS) Data Analysis Market Trepidation In 2025
Next Generation Sequencing (NGS) Data Analysis Market: Snapshot
NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing. Researchers are allowed to examine the biological systems, deeply due to exceptional throughput, scalability of systems, and speed by the next generation sequencing (NGS). In present times, a greater level of understanding is demanded due to the complexities involved…
Global Next Generation Sequencing (NGS) Market Is driven by Increased in adoptio …
The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for…
Next Generation Sequencing (NGS) at a CAGR of 23.59%
The Asia-Pacific NGS market which was worth $ 567.7 million in 2016 is poised to reach
$1,636.7 million by 2021 at a CAGR of 23.59%. Asia presents significant opportunities for the
investors/venture capitalists as the developed markets are saturated. The presence of noteworthy
developments by China and Japan for integration of new technologies and the development of
healthcare is majorly driving the Asia Pacific Market.
Sample Report Request: https://www.reportsandmarkets.com/sample-request/1214607-12/2016
R&D and…